Oncology device developer BioProtect said today it won FDA investigational device exemption approval to launch a pivotal clinical study of its ProSpace balloon system designed to prevent rectal toxicity following prostate cancer radiotherapy. The ProSpace balloon system is a novel balloon spacer designed to temporarily separate the rectum from the prostate during prostate cancer radiation therapy to […]
BioProtect
Prostate radiation treatment device dev BioProtect raises $3.5m
Oncology device developer BioProtect has raised $3.5 million to support the development of its BioProtect minimally invasive balloon implant designed to reduce rectal toxicity during prostate cancer radiation therapy. BioProtect’s biodegradable balloon implant is indicated for prostate cancer patients undergoing radiation therapy. The device is designed to separate the prostate and rectum to allow physicians […]